51 Orofacial clefts (OFCs) are one of the most common birth defects worldwide and create a 52 significant health burden. The majority of OFCs are non-syndromic, and the genetic component 53 has been only partially determined. Here, we analyze whole genome sequence (WGS) data for 54 association with risk of OFCs in European and Colombian families selected from a multicenter 55 family-based OFC study. Part of the Gabriella Miller Kids First Pediatric Research Program, this 56 is the first large-scale WGS study of OFC in parent-offspring trios. WGS provides deeper and 57 more specific genetic data than currently available using imputation on single nucleotide 58 polymorphic (SNP) marker panels. Here, association analysis of genome-wide single nucleotide 59 variants (SNV) and short insertions and deletions (indels) identified a new locus on chromosome 60 21 in Colombian families, within a region known to be expressed during craniofacial 61 development. This study reinforces the ancestry differences seen in the genetic etiology of OFCs, 62 and the need for larger samples when for studying OFCs and other birth defects in admixed 63 populations. 64
Introduction 65
Orofacial clefts, primarily cleft lip (CL) and cleft palate (CP) are among the most common 66 birth defects in all populations worldwide with differences in birth prevalence by ancestry (1, 2). 67
Surgical treatment along with ongoing orthodontia, speech and other therapies, are very 68 successful in ameliorating the physical health effects of OFC, but there is still a significant 69 social, emotional and financial burden for individuals with OFC, their families, and society (3, 70 4). Furthermore, there are disparities in access to such therapies for OFCs (5), similar to other 71 malformations with complex medical and surgical needs. Some studies have suggested a 72 reduced quality of life for individuals with OFCs (6), while other studies have identified higher 73 risk to certain types of cancers (7-9). Thus, it is critical to identify etiologic factors leading to 74
OFCs to improve diagnostics, treatments, and outcomes. 75
The causal genes for most syndromic forms of OFCs are now known, and listed within 76 OMIM (https://www.ncbi.nlm.nih.gov/omim, search criterion=(cleft lip cleft palate syndrome) 77 AND "omim snp" [Filter] ), but the majority of OFC cases -including about 70% of CL with or 78 without CP (CL/P) and 50% of CP alone -are considered non-syndromic, i.e. they occur as 79 isolated anomalies with no other apparent cognitive or structural abnormalities (1). The causal 80 genes for non-syndromic OFCs are still largely undiscovered. To date, there have been 52 81 genome-wide associations reported and replicated between non-syndromic CL/P and genetic 82 markers (NHGRI-EBI Catalog of published genome studies) (10), but as for most other complex 83 human traits (11-13), very few putative functional variants for non-syndromic OFCs have been 84 identified from genome-wide association studies (GWASs)(14). In particular, the high 85 heritability for OFC, estimated at 90% by a twin study in a Danish sample (15) cannot be 86 explained by all identified common variants significantly associated with OFC, sometimes 87 referred to as the "missing heritability" problem (16). Additional approaches will be necessary to 88 expand our understanding of genetic variation in nonsyndromic OFCs and whole genome 89 sequencing (WGS) holds the promise of teasing out the so-called missing heritability from 90
GWASs of OFC and other complex traits (17) . 91
An important new approach has been implemented by the Gabriella Miller Kids First 92
Pediatric Research Consortium (https://commonfund.nih.gov/kidsfirst/overview). Kids First was 93 established in 2015 to address gaps in our understanding of the genetic etiologies of structural 94 birth defects and pediatric cancers by providing WGS of case-parent trios with these major 95 pediatric conditions. Addressing both of these areas (structural birth defects and pediatric 96 cancers) in Kids First was partially motivated by the observation that children with birth defects 97 such as OFCs are at a higher risk of also developing some cancers, and their family members 98 also have elevated risk (7, 8) , suggesting there may be shared genetic pathways underlying 99 cancer and birth defects. The KidsFirst study consists of 952 case-parent trios (i.e. affected 100 probands and their parents) from multiple OFC studies, of which, 415 are of European descent, 101 275 Latino, 125 Asian and 137 African. The current study summarizes initial findings on 102 common variants, i.e. single nucleotide polymorphic (SNP) markers and small 103 insertions/deletions from WGS of a sample of 315 trios European descent, as well as a sample of 104 265 trios of Latin American ancestry from Colombia, all with offspring affected with cleft lip 105 with or without cleft palate (CL/P). 106
Results 107
Genome-wide association of SNPs and indels 108 Genome-wide associations using allelic and genotypic transmission disequilibrium test 109 (TDT) were run separately in 315 European and 265 Colombian trios and then in the 110
Combined set of all 580 trios on bi-allelic single nucleotide polymorphic (SNP) markers and 111 indels with minor allele frequency (MAF) greater than 10% (see Methods for discussion of the 112
MAF cutoff). A comparison of the p-values between allelic TDT (aTDT) and genotypic TDT 113
(gTDT) showed high concordance (see section "Comparison between aTDT and gTDT" and 114 supplementary figure S1 Figure 1) , therefore, only the aTDT results are discussed in the 115 following sections. P-values calculated using the exact binomial distribution from McNemar's 116 test are reported for the aTDT. 117 Tables 1 and 2 show the most significant results in the European (Table 1) and Colombian 118 trios (Table 2) . Several SNPs gave genome-wide significant association p-values in the stratified 119 aTDT analysis of European (Table 1 and Two of the genome-wide significant associations observed in this study, 1p36.13 and 8q24.21, have 160 been previously reported as associated with risk to OFCs by our group and others (19-21). The 1p36.13 161 peak is located 23kb upstream of the transcription start site of the PAX7 gene. These associations were 162 significant only in our European trios, consistent with previous studies suggesting a stronger 163 association in participants of European ancestry compared to other racial/ethnic groups (22). 164
The 8q24.21 region has been consistently implicated in nearly all previous OFC studies especially Colombia trios were part of the POFC Multiethnic study. However, the POFC Multiethnic study had 189 129 additional Colombian trios. In that study, the GWASs of Asian and European samples did not show 190 association in this region, and nor did the combined GWAS of all the POFC Multiethnic study samples. 191 The fact that the current WGS case-parent trio study yielded a genome-wide significant association with 192 a smaller sample size suggests this association might be unique to Colombians. We explored the 193 validity and implications of this observation through a number of analyses, as described below. 194
We first examined the aTDT p-values for our Colombian WGS trios using their SNP array data 195 from the POFC Multiethnic study. The p-values in this region were nearly identical to those observed in 196 our WGS association, confirming the association we observed here was not an artifact of sequencing. 197
We next investigated whether population substructure within the Colombian parents could have 198 caused the observed association in the WGS data by examining the ancestry principal components (PCs) 199 as well as results of quantitative association between PCA eigenvalues to variants within the peak region 200 (see Methods for details). PCA showed no evidence of population substructure (supplementary figure S1 201 Figure 2A ), and no association was observed between the eigenvalues and variants in the chromosome 202 21q22.3 region (supplementary figure S1 Figure 2B ). A positive association between eigenvalues and 203 variants would have indicated that the observed association with CL/P is in reality due to population 204 substructure, therefore, this association did not appear to be an artifact of population admixture. 205
We verified that this region does not show evidence of association in other Latin Americans, by 206 reanalyzing imputed genotype data from the previously published POFC Multiethnic GWAS study (23). 207 P-values from the aTDT of independent trios and the corresponding odds ratios at rs2839575 in each 208
Latino subpopulation were considerably different from those observed in the Colombian subjects 209 ( Figure 3A S3 Table) . We concluded from the stratified aTDT results that this 215 SNP influences OFC risk only in Colombians. Colombians compared to other Latino populations (supplementary figure S1 Figure 4) . Moreover, the 15 238 most significant SNPs in this peak region had higher allele frequencies in all other population groups 239 (European, African, and Asian) compared to Colombians or other Latinos. Thus, there was no 240 conclusive evidence that population-specific variants contributed to the association signal seen in this 241 study. However, several of these variants had estimated odds ratios between 1.1 and 1.5 in Asian, 242
Europeans, or Africans, suggesting these variants in this region may also increase risk for OFCs in other 243 populations, but at a reduced level. 244
Finally, we tested for effects of rare variants within the Colombian trios using burden and 245 collapsing tests because we observed a number of low-frequency and rare variants with large odds ratios 246 in this region (see Methods for rare variant testing procedure). Common variants with the strongest 247 associations were all intronic variants within the PDE9A gene; however, all had moderate odds ratios 248 around 2.0. In this region, there were 37 SNPs with minor allele frequencies near or below 1% in the 249
Colombian trios and estimated OR > 5 (supplementary table S4 Table) , including mainly intronic and a 250 few intergenic SNVs (28 intronic, 8 intergenic). The exception was one non-synonymous SNV, 251 rs138007679 in the RSPH1 gene (aTDT odds ratio 8, 95% CI = [1.001 ̶ 63.96]), which produces an 252 amino acid change (A>C, leucine to tryptophan according to ClinVar). Alone, this variant does not 253 clearly implicate RSPH1 over other genes in the region, so we performed a rare variant TDT on all non-254 synonymous variants within the 13 genes falling in this region. None of the individual genes achieved 255 the nominal significance (supplementary table S5 Table) , so this result remained inconclusive. We also 256 carried out rare variant TDTs of intronic and intergenic variants with similar results, finding only 257 nominally significant associations attributable to intergenic, low frequency variants (MAFs ranging 258 between 0.5% and 1%) . 259
In the absence of any clearly pathogenic variant or gene based on combined effects of rare 260 variants, we examined regulatory elements and protein-protein interaction pathways in this region with 261 respect to craniofacial development. All associated variants below a suggestive level of significance 262 (p<1.0e-05) were located within the PDE9A gene, which does not have any known role in controlling 263 risk to OFCs. However, the PDE9A gene overlaps a super-enhancer region for craniofacial development 264 identified from histone profiling in early human craniofacial development (25). Multiple genes in the 265 region, including PDE9A, appear to be actively transcribed during human craniofacial development 266 ( Figure 2 ). Another gene of interest is UBASH3A, located ~220kb centromeric to this peak signal. The 267 UBASH3A protein was previously shown to physically associate with SPRY2 via a yeast two-hybrid 268 assay (33). SPRY2 has been reported by GWASs of OFC and shown required for palatogenesis in mice 269 (26); whether UBASH3A is also expressed in craniofacial structures has not yet been determined. We observed evidence of linkage and association to a previously unreported region on chromosome 286 21 spanning the PDE9A gene only in the Colombian sample. We verified that this locus is unique to 287 Colombians, by running separate aTDTs in Colombian and non-Colombian Latino trios using imputed 288 genotype data from the previous POFC Multiethnic GWAS study (23). We examined whether the 289 apparent risk alleles have ancestral origins from non-Latino populations and noted that the estimated 290 effect sizes were slightly elevated in Asian, European and African populations although never achieving 291 genome-wide significance. However, larger or more phenotypically specific samples may be necessary 292 to find conclusive statistical evidence. The significantly associated common variants in the chromosome 293 21q22.3 peak were mostly intronic or intergenic, with no obvious biological function. There were a 294 number of rare variants with large aTDT odds ratios, including a non-synonymous SNP within the 295 RSPH1 gene, however, TDT of rare coding non-synonymous variants did not provide conclusive 296 statistical evidence of association between genes in this region and CL/P. Although none of the genes in 297 this region are known to contribute to the development of OFCs, they appear to be actively transcribed 298
during human craniofacial development and should be examined further in follow up studies. 299 and Colombian respectively, in this study. Recruitment of participants and phenotypic assessments were 305 done at regional treatment centers for orofacial clefts after review and approval by the site-specific 306
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IRBs. 307
This study included case-parent trios consisting of affected offspring and their parents (see Table 3 ). 308
Most of the European parents and all Colombian parents are unaffected for CL/P (see breakdown of 309 trios in Table 3 ). All trios had offspring with a cleft lip or a cleft lip plus cleft palate, and had not been 310 diagnosed with any recognized genetic syndrome. The affection status was defined as cleft lip with or 311 without cleft palate (CL/P) for all analyses here because the Colombian sample did not have the 312 breakdown between cleft lip alone (CL) versus cleft lip with cleft palate (CLP). Table 3 shows the 313 counts of GMKF trios sequenced for the present study, by their country of origin. 314 315
Sample
Total Trios
Trios with no affected parents
Trios with 1 affected parent European  315  280  32  3  Site: USA  209  185  21  3  Hungary  56  51  5  Madrid  30  26  4  Argentina  1  1  Turkey  19  17  2  Colombian  265  265  Total  580  545  32  3  Table 3 We subsequently examined lower-MAF SNPs in specific regions for fine-mapping purposes (see 394 below). The genome-wide threshold for significant association was set at 5.0e-08, and the critical value 395 for suggestive association was set at 1.0e-05. 396
Trios with 2 affected parents
Fine mapping and rare-variant association in 21q region 397 A subset of the genome-wide significant associations (i.e. those not overlapping with previously 398 reported OFC genes/regions) was selected for more in-depth investigation. All biallelic variants with a 399 genotyping rate of 90% or greater, regardless of MAF, were investigated within each region of interest 400 (defined as 1Mb centered on each lead variant). Each interval was annotated for possible roles in 401 craniofacial development by literature searches of all genes contained within that interval, functional 402 annotation of variants using multiple tools including Bystro (39), Variant Effect Predictor (40), and 403 HaploReg (41). We also queried the UCSC genome browser's gene-by-gene interaction track for known 404 OFC genes/regions. This track identifies genes reported in protein-interaction databases and recognized 405 biological pathways (42). 406
Rare variant (RV) association using the TDT framework was run only for regions containing SNPs 407 showing significant evidence of linkage and association in the aTDT. For each association peak, we 408 identified all genes located within 500 KB of the lead SNP, and selected non-synonymous RVs within 409 the exons of these genes. Burden and collapsing methods were used, as our dataset is composed solely 410 of case-parent trios, and these tests were applied to each gene separately, after phasing the observed 411 genotype data of common SNPs. Beagle was used to calculate haplotypes (43) using all variants within a 412 selected region. The RV-TDT software (44) was then run on phased haplotypes for exonic, non-413 synonymous SNVs in genes with a minimum of 4 variant sites. RV-TDT reports burden and combined 414 multivariate and collapsing (CMC)-types of test statistics, as well as a weighted sum statistic. The 415 observed MAFs within European and Colombian parents were used to calculate weights for each RV, 416
where SNVs with smaller MAFs receiving higher weights. Some of the RV-TDT statistics use phased 417 haplotypes to calculate empirical p-values by permuting the haplotypes of each parent. In addition to the 418 exonic rare variants, we also selected intronic and intergenic variants and analyzed these using RV-TDT. 419
Intronic and intergenic variants were divided up into subsets based on gene locations in this region, and 420 analyzed using a procedure similar to the exonic, non-synonymous SNPs. 
